<DOC>
	<DOCNO>NCT02374684</DOCNO>
	<brief_summary>The purpose study determine safety tolerability , evaluate pharmacokinetic characteristic food effect Methosulide oral administration healthy adult subject .</brief_summary>
	<brief_title>Tolerability , Safety Pharmacokinetic Study Of Methosulide Healthy Adult Subjects</brief_title>
	<detailed_description>1 . Dose-escalation study single oral administration Methosulide healthy adult assess safety tolerability . 2 . Multiple-dose study Methosulide healthy adult assess safety tolerability . 3 . Dose-escalation study single oral administration Methosulide healthy adult evaluate pharmacokinetic characteristic 4 . Multiple-dose study Methosulide healthy adult evaluate pharmacokinetics characteristic 5 . Single dose , cross-over study Methosulide healthy adult evaluate pharmacokinetic characteristic effect food .</detailed_description>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Male female , 18 45 year age , Body Mass Index ( BMI ) 19ï½ž25 kg/m2 , Weight &gt; = 50kg In good health judge investigator Without history medication within 2 week test Nonallergic constitution , without know drug allergy Without history major organ disease Without factor affect drug metabolism , smoking ( within 2 week ) , drink ( within 2 week ) , drug abuse history Signed informed consent form Fully understood content , process possible adverse reaction test History kind food drug allergy , suffer allergic disease allergic constitution Presence ( screen stage ) history acute/chronic organic disease clinical manifestation : blood system , renal disease , endocrine system , respiratory system , digestive system , cardiovascular system , nervous system , mental disease , allergic disease ( include drug allergy , include nontreatment , asymptomatic , seasonal allergy period oral administration ) History abuse Smoking , alcohol , drug Severe hemorrhage factor affect venous blood collection Severe blood loss blood donation within 3 month test Participation drug trial within 3 month test Usage drug know damage main organ within 3 month test Without good compliance , unable match test clinically significant abnormality routine serological detection : include Hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) , human immunodeficiency virus ( HIV ) infect For childbearingaged woman , usage hormonal contraceptive method within 3 month drug administration ; unable unwilling use nonhormonal contraceptive method contraception day dose 14 day dose Be otherwise unsuitable study , opinion Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Anti-Inflammatory Agents , Non-Steroidal</keyword>
</DOC>